ProQR Therapeutics (PRQR) Profit After Tax Growth (3y) (2016 - 2025)
ProQR Therapeutics (PRQR) Profit After Tax Growth (3y) (2016 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PAT Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
33.21% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
30.60% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-154.28% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
16.53% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
ProQR Therapeutics |
7.27 Mn |
-100.30 Mn |
- |
-86.36% |
| Date | Value |
|---|
| Dec 31, 2025 |
-86.36% |
| Sep 30, 2025 |
18.19% |
| Jun 30, 2025 |
43.55% |
| Mar 31, 2025 |
38.72% |
| Dec 31, 2024 |
-35.29% |
| Sep 30, 2024 |
-35.74% |
| Jun 30, 2024 |
29.12% |
| Mar 31, 2024 |
18.24% |
| Dec 31, 2023 |
-33.40% |
| Sep 30, 2023 |
27.38% |
| Jun 30, 2023 |
57.60% |
| Mar 31, 2023 |
18.79% |
| Dec 31, 2022 |
-38.55% |
| Sep 30, 2022 |
-55.11% |
| Jun 30, 2022 |
-45.67% |
| Mar 31, 2022 |
-43.88% |
| Dec 31, 2021 |
1,021.51% |
| Sep 30, 2021 |
36.62% |
| Jun 30, 2021 |
-60.68% |
| Mar 31, 2021 |
-10,395.13% |
